Automated description from the Alliance of Genome Resources
Exhibits PDZ domain binding activity and phosphatidylinositol-3,4-bisphosphate binding activity. Predicted to be involved in positive regulation of cell-matrix adhesion. Predicted to localize to the cytoplasm; membrane; and protein-containing complex. Is expressed in several structures, including central nervous system; clavicle; cranium; jaw; and thymus primordium. Orthologous to human PLEKHA2 (pleckstrin homology domain containing A2).